Stanley J. Schmidt

Discovery of GSK2126458, a Highly Potent Inhibitor of PI3K and the Mammalian Target of Rapamycin

Steven D. Knight, Nicholas D. Adams, Joelle L. Burgess et al. · ACS Medicinal Chemistry Letters · 2010 · 372 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +13

New IDH1 mutant inhibitors for treatment of acute myeloid leukemia

Ujunwa Cynthia Okoye-Okafor, Boris Bartholdy, Jessy Cartier et al. · Nature Chemical Biology · 2015 · 176 citations · Full text

Medicine, Hematology, Oncology +12

P1 Aspartate-Based Peptide .alpha.-((2,6-Dichlorobenzoyl)oxy)methyl Ketones as Potent Time-Dependent Inhibitors of Interleukin-1.beta.-Converting Enzyme

Roland E. Dolle, C. V. C. Prasad, Stanley J. Schmidt et al. · Journal of Medicinal Chemistry · 1994 · 147 citations

Life Sciences, Biochemistry, Pharmacology +12

Discovery of GSK1070916, a Potent and Selective Inhibitor of Aurora B/C Kinase

Nicholas D. Adams, Jerry L. Adams, Joelle L. Burgess et al. · Journal of Medicinal Chemistry · 2010 · 111 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14

Palladium catalysed alkoxycarbonylation of phenols to benzoate esters

Roland E. Dolle, Stanley J. Schmidt, Lawrence I. Kruse · Journal of the Chemical Society Chemical Communications · 1987 · 98 citations

Natural Sciences, Chemistry, Catalysis +6